Zhenbin Shen

1.2k total citations
36 papers, 909 citations indexed

About

Zhenbin Shen is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Zhenbin Shen has authored 36 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in Zhenbin Shen's work include Gastric Cancer Management and Outcomes (10 papers), Immune cells in cancer (8 papers) and Immune Cell Function and Interaction (6 papers). Zhenbin Shen is often cited by papers focused on Gastric Cancer Management and Outcomes (10 papers), Immune cells in cancer (8 papers) and Immune Cell Function and Interaction (6 papers). Zhenbin Shen collaborates with scholars based in China and United States. Zhenbin Shen's co-authors include Yihong Sun, Xuefei Wang, Jiejie Xu, Jing Qin, Xinyu Qin, Heng Zhang, Heng Zhang, Chao Lin, Hao Liu and Yuanyuan Ruan and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Zhenbin Shen

35 papers receiving 904 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenbin Shen China 17 413 361 337 251 194 36 909
Wataru Sakamoto Japan 19 396 1.0× 393 1.1× 279 0.8× 131 0.5× 152 0.8× 65 837
Liye Ma China 15 257 0.6× 331 0.9× 231 0.7× 157 0.6× 159 0.8× 28 742
Wenyi Zhao China 18 236 0.6× 445 1.2× 133 0.4× 231 0.9× 337 1.7× 43 879
Raffaela Santoro Italy 18 363 0.9× 437 1.2× 90 0.3× 139 0.6× 215 1.1× 28 874
Shinichi Umeda Japan 16 186 0.5× 356 1.0× 66 0.2× 191 0.8× 136 0.7× 58 624
Zaozao Wang China 18 217 0.5× 470 1.3× 60 0.2× 185 0.7× 332 1.7× 48 802
Hao‐Chen Wang Taiwan 15 342 0.8× 420 1.2× 253 0.8× 80 0.3× 190 1.0× 30 934
Zhongyin Yang China 14 152 0.4× 318 0.9× 77 0.2× 198 0.8× 174 0.9× 39 612
Fumiko Chiwaki Japan 16 179 0.4× 465 1.3× 87 0.3× 156 0.6× 178 0.9× 27 718

Countries citing papers authored by Zhenbin Shen

Since Specialization
Citations

This map shows the geographic impact of Zhenbin Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenbin Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenbin Shen more than expected).

Fields of papers citing papers by Zhenbin Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenbin Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenbin Shen. The network helps show where Zhenbin Shen may publish in the future.

Co-authorship network of co-authors of Zhenbin Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenbin Shen. A scholar is included among the top collaborators of Zhenbin Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenbin Shen. Zhenbin Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Cao, Yifan, Kuan Yu, Zihao Zhang, et al.. (2024). Blockade of V‐domain immunoglobulin suppressor of T‐cell activation reprograms tumour‐associated macrophages and improves efficacy of PD‐1 inhibitor in gastric cancer. Clinical and Translational Medicine. 14(2). e1578–e1578. 10 indexed citations
4.
Wang, Xuefei, Junjie Zhao, Zhenbin Shen, et al.. (2020). Multidisciplinary Approach in Improving Survival Outcome of Early-Stage Gastric Cancer. Journal of Surgical Research. 255. 285–296. 11 indexed citations
5.
Fang, Hanji, Yun Gu, Yuchao Fei, et al.. (2020). Intratumoral interleukin-9 delineates a distinct immunogenic class of gastric cancer patients with better prognosis and adjuvant chemotherapeutic response. OncoImmunology. 9(1). 1856468–1856468. 13 indexed citations
6.
Zeng, Xiaoqing, Hao Wu, Wei Yuan, et al.. (2019). Transcriptional activation of ANO1 promotes gastric cancer progression. Biochemical and Biophysical Research Communications. 512(1). 131–136. 21 indexed citations
9.
Liu, Hao, Zhenbin Shen, Zhenglin Wang, et al.. (2016). Increased expression of IDO associates with poor postoperative clinical outcome of patients with gastric adenocarcinoma. Scientific Reports. 6(1). 21319–21319. 78 indexed citations
10.
Wu, Song‐Yang, Hao Liu, Heng Zhang, et al.. (2016). Galectin-8 is associated with recurrence and survival of patients with non-metastatic gastric cancer after surgery. Tumor Biology. 37(9). 12635–12642. 17 indexed citations
11.
Cao, Yifan, Hao Liu, Heng Zhang, et al.. (2016). Decreased expression of Siglec-8 associates with poor prognosis in patients with gastric cancer after surgical resection. Tumor Biology. 37(8). 10883–10891. 7 indexed citations
12.
Peng, Peike, Weicheng Wu, Junjie Zhao, et al.. (2016). Decreased expression of Calpain-9 predicts unfavorable prognosis in patients with gastric cancer. Scientific Reports. 6(1). 29604–29604. 23 indexed citations
13.
Ling, Chen, Lingqiang Min, Xuefei Wang, et al.. (2015). Loss of RACK1 Promotes Metastasis of Gastric Cancer by Inducing a miR-302c/IL8 Signaling Loop. Cancer Research. 75(18). 3832–3841. 83 indexed citations
14.
Wang, Zhenglin, Hao Liu, Zhenbin Shen, et al.. (2015). The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients. BMC Cancer. 15(1). 766–766. 31 indexed citations
15.
Wang, Yan, Yiyi Yu, Wěi Li, et al.. (2014). A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis. Cancer Chemotherapy and Pharmacology. 73(6). 1155–1161. 45 indexed citations
16.
Zhang, Heng, Xuefei Wang, Zhenbin Shen, et al.. (2014). Infiltration of diametrically polarized macrophages predicts overall survival of patients with gastric cancer after surgical resection. Gastric Cancer. 18(4). 740–750. 113 indexed citations
17.
Wang, Xuefei, Hongyong He, Heng Zhang, et al.. (2012). Clinical and prognostic implications of β1, 6‐N‐acetylglucosaminyltransferase V in patients with gastric cancer. Cancer Science. 104(2). 185–193. 18 indexed citations
18.
Li, Haojie, Zhenbin Shen, Yihong Sun, et al.. (2012). [Association of T helper cell 1 cytokines expressions with prognosis of gastric cancer patients].. PubMed. 15(6). 618–21. 1 indexed citations
19.
He, Hongyong, Weidong Chen, Xuefei Wang, et al.. (2012). Snail is an independent prognostic predictor for progression and patient survival of gastric cancer. Cancer Science. 103(7). 1296–1303. 34 indexed citations
20.
Wang, Cong, et al.. (2009). Relationship between clinicopathologic factors and prognosis of patients with early gastric cancer.. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 8(5). 338–340. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026